PL4208152T3 - Nisko higroskopijne aktywne kompozycje proszku - Google Patents

Nisko higroskopijne aktywne kompozycje proszku

Info

Publication number
PL4208152T3
PL4208152T3 PL21763145.6T PL21763145T PL4208152T3 PL 4208152 T3 PL4208152 T3 PL 4208152T3 PL 21763145 T PL21763145 T PL 21763145T PL 4208152 T3 PL4208152 T3 PL 4208152T3
Authority
PL
Poland
Prior art keywords
powder compositions
active powder
low hygroscopic
hygroscopic active
low
Prior art date
Application number
PL21763145.6T
Other languages
English (en)
Inventor
Fabiana SPADARO
Gerard Zuber
Original Assignee
Philip Morris Products S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products S.A. filed Critical Philip Morris Products S.A.
Publication of PL4208152T3 publication Critical patent/PL4208152T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/452Piperidinium derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Seasonings (AREA)
PL21763145.6T 2020-09-03 2021-08-31 Nisko higroskopijne aktywne kompozycje proszku PL4208152T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20194434 2020-09-03
PCT/IB2021/057952 WO2022049487A1 (en) 2020-09-03 2021-08-31 Low hygroscopicity active powder compositions

Publications (1)

Publication Number Publication Date
PL4208152T3 true PL4208152T3 (pl) 2025-09-22

Family

ID=72380903

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21763145.6T PL4208152T3 (pl) 2020-09-03 2021-08-31 Nisko higroskopijne aktywne kompozycje proszku

Country Status (17)

Country Link
US (1) US20230310315A1 (pl)
EP (1) EP4208152B1 (pl)
JP (1) JP2023540190A (pl)
KR (1) KR20230061366A (pl)
CN (1) CN116096253A (pl)
AU (1) AU2021335792A1 (pl)
BR (1) BR112023001929A2 (pl)
CA (1) CA3185270A1 (pl)
ES (1) ES3036665T3 (pl)
HU (1) HUE072114T2 (pl)
IL (1) IL300741A (pl)
MX (1) MX2023002466A (pl)
PH (1) PH12023550163A1 (pl)
PL (1) PL4208152T3 (pl)
UA (1) UA130350C2 (pl)
WO (1) WO2022049487A1 (pl)
ZA (1) ZA202213470B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024090890A1 (ko) * 2022-10-27 2024-05-02 주식회사 케이티앤지 흡입용 저용량 니코틴 건조 분말 조성물
CN120417888A (zh) * 2022-10-27 2025-08-01 韩国烟草人参公社 用于吸入的尼古丁干粉的制备方法
KR20240164039A (ko) 2023-05-11 2024-11-19 주식회사 엘지화학 폐플라스틱의 열분해유 제조 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514393A (ja) * 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
CA2744655A1 (en) * 2008-11-27 2010-06-03 Boehringer Ingelheim International Gmbh Novel powdered crystalline medicines for inhalation
US8207346B2 (en) 2010-03-23 2012-06-26 Rock Creek Pharmaceuticals, Inc. Methods of synthesizing anatabine
PL2549995T3 (pl) 2010-03-23 2021-09-27 Philip Morris Products S.A. Zastosowanie anatabiny w leczeniu stanów zapalnych i metody syntezy anatabiny
WO2011159633A1 (en) * 2010-06-15 2011-12-22 Amira Pharmaceuticals, Inc. Inhalable formulations of lysophosphatdic acid receptor antagonists
US20130298921A1 (en) * 2011-06-23 2013-11-14 Rock Creek Pharmaceuticals, Inc. Inhaler for smoking cessation
HK1199733A1 (en) 2011-08-29 2015-07-17 Philip Morris Products S.A. Products for anti-inflammation support
RU2767064C2 (ru) * 2016-06-30 2022-03-16 Филип Моррис Продактс С.А. Никотиносодержащие частицы и композиции
EP3478265B1 (en) * 2016-06-30 2025-01-01 Philip Morris Products S.A. Nicotine particles
IL269275B2 (en) * 2017-06-28 2023-04-01 Philip Morris Products Sa Container with particles for use with an inhaler
CN113039180A (zh) 2018-12-17 2021-06-25 菲利普莫里斯生产公司 3-(1,2,3,6-四氢吡啶-2-基)吡啶戊二酸盐或其药学上可接受的溶剂化物

Also Published As

Publication number Publication date
MX2023002466A (es) 2023-05-19
EP4208152C0 (en) 2025-07-16
IL300741A (en) 2023-04-01
AU2021335792A1 (en) 2023-02-02
CA3185270A1 (en) 2022-03-10
EP4208152B1 (en) 2025-07-16
KR20230061366A (ko) 2023-05-08
WO2022049487A1 (en) 2022-03-10
CN116096253A (zh) 2023-05-09
HUE072114T2 (hu) 2025-10-28
ZA202213470B (en) 2025-11-26
PH12023550163A1 (en) 2024-03-18
UA130350C2 (uk) 2026-01-28
ES3036665T3 (en) 2025-09-23
BR112023001929A2 (pt) 2023-03-14
EP4208152A1 (en) 2023-07-12
US20230310315A1 (en) 2023-10-05
JP2023540190A (ja) 2023-09-22

Similar Documents

Publication Publication Date Title
EP4227390A4 (en) COMPOSITION CONTAINING A REFRIGERANT FLUID
EP4148096A4 (en) COMPOSITION
EP4094582A4 (en) COMPOSITION
PL4208152T3 (pl) Nisko higroskopijne aktywne kompozycje proszku
EP4328279A4 (en) COMPOSITION
EP4115893A4 (en) Anti-tumor composition
EP4279545A4 (en) COMPOSITION
EP4304549A4 (en) Antibiofilm preservative compositions
EP4313320A4 (en) ANTIPERSPIRANT COMPOSITION
EP3977855A4 (en) Stable microbicide composition
EP4281046C0 (en) NALTREXONE-BASED COMPOSITIONS
EP4284362A4 (en) Formulations
EP4256012C0 (en) COMPOSITION
EP4291042C0 (en) COMPOSITION DERIVED FROM OATS
EP4271359C0 (en) ORODISPPERABLE POWDER COMPOSITION
EP4326245A4 (en) Antimicrobial compositions
EP4504168A4 (en) COMPOSITIONS CONTAINING CANNABINOIDS
IL310652A (en) Formulations of radiprodil
EP4236959A4 (en) CAFFEINE COMPOSITIONS
EP4318634A4 (en) ALL-SOLID-STATE BATTERY COMPOSITION
EP4330366C0 (en) COMPOSITION
EP4469037A4 (en) ANTIMICROBIAL COMPOUNDS
EP4223850A4 (en) COMPOSITION
EP4188088A4 (en) Formulations
EP4175676A4 (en) MUCO-PENETRATING FORMULATIONS